Thus, SUMOylation can impinge on the aetiology of α-synucleinopathy in one of two ways, either by modulating the propensity of α-synuclein to aggregate or by affecting the action of the cellular degradative machinery in clearance of α-synuclein aggregates, or indeed by a combination of both. This evidence concerns the gene SNCA and synucleinopathy.